{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:12:22Z","timestamp":1770984742431,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Postoperative pain in ambulatory surgery is a multifactorial issue affecting patient satisfaction, time of discharge, and rehospitalization. This study evaluated the efficacy and safety of nalbuphine for the treatment of postoperative pain after ambulatory surgery, relative to tramadol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This multi-center, randomized, double blind, and controlled study was conducted at 10 centers. In accordance with the inclusion criteria, 492 ambulatory surgery patients were recruited. These patients had moderate to severe pain after ambulatory surgery, with a visual analogue scale (VAS) score\u2009&gt;\u20093\u2009cm. They were randomly divided into an experimental (<jats:italic>n<\/jats:italic>\u2009=\u2009248) or control (<jats:italic>n<\/jats:italic>\u2009=\u2009244) group and treated for analgesia with 0.2\u2009mg\/kg of nalbuphine or 2\u2009mg\/kg of tramadol, respectively. VAS scores, adverse events, and vital signs of the patients were recorded before administration (baseline; T<jats:sub>1<\/jats:sub>); and 30\u2009min (T<jats:sub>2<\/jats:sub>), 2\u2009h (T<jats:sub>3<\/jats:sub>), 4\u2009h (T<jats:sub>4<\/jats:sub>), and 6\u2009h (T<jats:sub>5<\/jats:sub>) after administration of analgesia. A decrease in pain intensity of more than 25% compared with the baseline was used as an indicator of analgesic efficacy. The experimental and control groups were compared with regard to this indicator of efficacy at each timepoint.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The VAS scores of the experimental and control groups were statistically comparable at timepoints T<jats:sub>1<\/jats:sub>-T<jats:sub>4<\/jats:sub>. At T<jats:sub>5<\/jats:sub>, the VAS scores of the experimental group were significantly lower than that of the control. The pain intensity was significantly higher in the experimental group compared with the control at T<jats:sub>2<\/jats:sub>and T<jats:sub>3<\/jats:sub>. Adverse events and vital signs were similar for the two groups at each timepoint.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Nalbuphine can provide effective and safe pain relief in patients after ambulatory surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>The registration number is<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=16800\">ChiCTR-IOR-16010032<\/jats:ext-link>, the date of registration was 2016-11-28.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12871-020-01125-4","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T11:02:49Z","timestamp":1597489369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pain management after ambulatory surgery: a prospective, multicenter, randomized, double-blinded parallel controlled trial comparing nalbuphine and tramadol"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu-jiao","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-wu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-hong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang-jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qu-lian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-gang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,15]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00540-004-0297-6","volume":"19","author":"G Shirakami","year":"2005","unstructured":"Shirakami G, Teratani Y, Namba T, Hirakata H, Tazuke-Nishimura M, Fukuda K. Delayed discharge and acceptability of ambulatory surgery in adult outpatients receiving general anesthesia. J Anesth. 2005;19:93\u2013101. https:\/\/doi.org\/10.1007\/s00540-004-0297-6.","journal-title":"J Anesth"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0039-6109(05)70389-3","volume":"79","author":"D Tong","year":"1999","unstructured":"Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am. 1999;79:401\u201330.","journal-title":"Surg Clin North Am"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bpa.2006.11.005","volume":"21","author":"N Rawal","year":"2007","unstructured":"Rawal N. Postoperative pain treatment for ambulatory surgery. Best Pract Res Clin Anaesthesiol. 2007;21:129\u201348.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5489\/cuaj.11002","volume":"5","author":"M Melnyk","year":"2011","unstructured":"Melnyk M, Casey RG, Black P, Koupparis AJ. Enhanced recovery after surgery (ERAS) protocols: Time to change practice? Can Urol Assoc J. 2011;5:342\u20138. https:\/\/doi.org\/10.5489\/cuaj.11002.","journal-title":"Can Urol Assoc J"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4097\/kjae.2017.70.4.398","volume":"70","author":"JH Lee","year":"2017","unstructured":"Lee JH. Anesthesia for ambulatory surgery. Korean J Anesthesiol. 2017;70:398\u2013406. https:\/\/doi.org\/10.4097\/kjae.2017.70.4.398.","journal-title":"Korean J Anesthesiol"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00000539-200101000-00040","volume":"92","author":"I Acalovschi","year":"2001","unstructured":"Acalovschi I, Cristea T, Margarit S, Gavrus R. Tramadol added to lidocaine for intravenous regional anesthesia. Anesth Analg. 2001;92:209\u201314.","journal-title":"Anesth Analg"},{"key":"1125_CR7","first-page":"521","volume":"74","author":"RJ Jankovic","year":"2008","unstructured":"Jankovic RJ, Visnjic MM, Milic DJ, Stojanovic MP, Djordjevic DR, Pavlovic MS. Does the addition of ketorolac and dexamethasone to lidocaine intravenous regional anesthesia improve postoperative analgesia and tourniquet tolerance for ambulatory hand surgery? Minerva Anestesiol. 2008;74:521\u20137.","journal-title":"Minerva Anestesiol"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4103\/0970-9185.101941","volume":"28","author":"A Kumar","year":"2012","unstructured":"Kumar A, Sharma D, Datta B. Addition of ketamine or dexmedetomidine to lignocaine in intravenous regional anesthesia: A randomized controlled study. J Anaesthesiol Clin Pharmacol. 2012;28:501\u20134. https:\/\/doi.org\/10.4103\/0970-9185.101941.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/AAP.0000000000000128","volume":"39","author":"HS Abdel-Ghaffar","year":"2014","unstructured":"Abdel-Ghaffar HS, Kalefa MA, Imbaby AS. Efficacy of ketamine as an adjunct to lidocaine in intravenous regional anesthesia. Reg Anesth Pain Med. 2014;39:418\u201322. https:\/\/doi.org\/10.1097\/AAP.0000000000000128.","journal-title":"Reg Anesth Pain Med"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/1687-7934.133441","volume":"7","author":"MIEN Youssef","year":"2014","unstructured":"Youssef MIEN. Lidocaine-nalbuphine versus lidocaine-tramadol for intravenous regional anesthesia. Ain-Shams J Anesthesiol. 2014;7:198\u2013204.","journal-title":"Ain-Shams J Anesthesiol"},{"key":"1125_CR11","first-page":"575","volume":"19","author":"MH Bakri","year":"2016","unstructured":"Bakri MH, Ismail EA, Abd-Elshafy SK. Analgesic effect of Nalbuphine when added to intravenous regional anesthesia: a randomized control trial. Pain Physician. 2016;19:575\u201381.","journal-title":"Pain Physician"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1463-1326.2009.01073.x","volume":"11 Suppl 3","author":"T Vilsb\u00f8ll","year":"2009","unstructured":"Vilsb\u00f8ll T. The effects of glucagon-like peptide-1 on the beta cell. Diabetes Obes Metab. 2009;11 Suppl 3:11\u20138. https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01073.x.","journal-title":"Diabetes Obes Metab"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00001665-200103000-00007","volume":"12","author":"D Shin","year":"2001","unstructured":"Shin D, Kim S, Kim CS, Kim HS. Postoperative pain management using intravenous patient-controlled analgesia for pediatric patients. J Craniofac Surg. 2001;12:129\u201333.","journal-title":"J Craniofac Surg"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/0259-1162.94759","volume":"5","author":"A Mukherjee","year":"2011","unstructured":"Mukherjee A, Pal A, Agrawal J, Mehrotra A, Dawar N. Intrathecal nalbuphine as an adjuvant to subarachnoid block: What is the most effective dose? Anesth Essays Res. 2011;5:171\u20135. https:\/\/doi.org\/10.4103\/0259-1162.94759.","journal-title":"Anesth Essays Res"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s00520-019-4643-5","volume":"27","author":"X Hua","year":"2019","unstructured":"Hua X, Chen LM, Zhu Q, Hu W, Lin C, Long ZQ, et al. Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial. Support Care Cancer. 2019;27:3759\u201367. https:\/\/doi.org\/10.1007\/s00520-019-4643-5.","journal-title":"Support Care Cancer"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/EJA.0b013e328324b747","volume":"26","author":"M Ali","year":"2009","unstructured":"Ali M, Khan FA. Comparison of analgesic effect of tramadol alone and a combination of tramadol and paracetamol in day-care laparoscopic surgery. Eur J Anaesthesiol. 2009;26:475\u20139. https:\/\/doi.org\/10.1097\/EJA.0b013e328324b747.","journal-title":"Eur J Anaesthesiol"},{"key":"1125_CR17","unstructured":"Chow S-C, Shao J, Wang H. Sample size calculations in clinical research (2nd ed). Boca Raton: Chapman & Hall\/CRC; 2008."},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1213\/01.ANE.0000068822.10113.9E","volume":"97","author":"JL Apfelbaum","year":"2003","unstructured":"Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534\u201340 table of contents.","journal-title":"Anesth Analg"},{"key":"1125_CR19","doi-asserted-by":"publisher","unstructured":"Aubrun F, Ecoffey C, Benhamou D, Jouffroy L, Diemunsch P, Skaare K, et al. Perioperative pain and post-operative nausea and vomiting (PONV) management after day-case surgery: The SFAR-OPERA national study. Anaesth Crit Care Pain Med. 2018. https:\/\/doi.org\/10.1016\/j.accpm.2018.08.004.","DOI":"10.1016\/j.accpm.2018.08.004"},{"key":"1125_CR20","first-page":"812","volume":"08","author":"J Xu","year":"2017","unstructured":"Xu J. Expert consensus on analgesia afteradult day surgery. J Clin Anesthesiol. 2017;08:812\u20135.","journal-title":"J Clin Anesthesiol"},{"key":"1125_CR21","unstructured":"Web site:LABEL: NALBUPHINE HYDROCHLORIDE- nalbuphine hydrochloride injection, solution. Available at: https:\/\/www.dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6025e8d4-5083-4c3a-58a0-050e7b0b6150. Accessed 26 Feb 2020."},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/laban.701","volume":"44","author":"HL Narver","year":"2015","unstructured":"Narver HL. Nalbuphine, a non-controlled opioid analgesic, and its potential use in research mice. Lab Anim (NY). 2015;44:106\u201310. https:\/\/doi.org\/10.1038\/laban.701.","journal-title":"Lab Anim (NY)"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"10927","DOI":"10.1038\/srep10927","volume":"5","author":"Z Zeng","year":"2015","unstructured":"Zeng Z, Lu J, Shu C, Chen Y, Guo T, Wu QP, et al. A comparision of nalbuphine with morphine for analgesic effects and safety : meta-analysis of randomized controlled trials. Sci Rep. 2015;5:10927. https:\/\/doi.org\/10.1038\/srep10927.","journal-title":"Sci Rep"},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kjms.2014.01.001","volume":"30","author":"MK Chen","year":"2014","unstructured":"Chen MK, Chau SW, Shen YC, Sun YN, Tseng KY, Long CY, et al. Dose-dependent attenuation of intravenous nalbuphine on epidural morphine-induced pruritus and analgesia after cesarean delivery. Kaohsiung J Med Sci. 2014;30:248\u201353. https:\/\/doi.org\/10.1016\/j.kjms.2014.01.001.","journal-title":"Kaohsiung J Med Sci"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S0929-6646(09)60372-7","volume":"108","author":"YC Yeh","year":"2009","unstructured":"Yeh YC, Lin TF, Chang HC, Chan WS, Wang YP, Lin CJ, et al. Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects. J Formos Med Assoc. 2009;108:548\u201353. https:\/\/doi.org\/10.1016\/S0929-6646(09)60372-7.","journal-title":"J Formos Med Assoc"},{"key":"1125_CR26","first-page":"330","volume":"38","author":"S Zhang","year":"2016","unstructured":"Zhang S. Clinical observation of low-dose nalbuphine combinedwith sufentanil in PCIA. Acta Acad Med WeiFang. 2016;38:330\u20132.","journal-title":"Acta Acad Med WeiFang"},{"key":"1125_CR27","first-page":"84","volume":"17","author":"NYT Niu","year":"2017","unstructured":"Niu NYT. nalbuphine combined with sufentanil for clinical observation of analgesia afteradult laparoscopic surgery. World Med Inform Digest. 2017;17:84\u20136.","journal-title":"World Med Inform Digest"},{"key":"1125_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/joacp.JOACP_210_16","volume":"34","author":"M Gupta","year":"2018","unstructured":"Gupta M, Gupta P. Nalbuphine pretreatment for prevention of etomidate induced myoclonus: A prospective, randomized and double-blind study. J Anaesthesiol Clin Pharmacol. 2018;34:200\u20134. https:\/\/doi.org\/10.4103\/joacp.JOACP_210_16.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"1125_CR29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/clpt.1980.67","volume":"27","author":"A Romagnoli","year":"1980","unstructured":"Romagnoli A, Keats AS. Ceiling effect for respiratory depression by nalbuphine. Clin Pharmacol Ther. 1980;27:478\u201385.","journal-title":"Clin Pharmacol Ther"},{"key":"1125_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00101-014-2293-z","volume":"63","author":"AM Schultz-Machata","year":"2014","unstructured":"Schultz-Machata AM, Becke K, Weiss M. Nalbuphine in pediatric anesthesia. Anaesthesist. 2014;63:135\u201343. https:\/\/doi.org\/10.1007\/s00101-014-2293-z.","journal-title":"Anaesthesist"},{"key":"1125_CR31","first-page":"211","volume":"28","author":"AM Tariq","year":"2014","unstructured":"Tariq AM, Z. Iqbal and Qadirullah. Efficacy of nalbuphine in preventing haemodynamic response to laryngoscopy and intubation. J Postgrad Med Inst. 2014;28:211\u20136.","journal-title":"J Postgrad Med Inst"},{"key":"1125_CR32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4103\/0970-9185.74584","volume":"26","author":"PM Chawda","year":"2010","unstructured":"Chawda PM, Pareek MK, Mehta KD. Effect of nalbuphine on haemodynamic response to orotracheal intubation. J Anaesthesiol Clin Pharmacol. 2010;26:458\u201360.","journal-title":"J Anaesthesiol Clin Pharmacol"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-020-01125-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-020-01125-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-020-01125-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T01:58:16Z","timestamp":1667786296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-020-01125-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s12871-020-01125-4","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Xiangya Hospital of Central South University (IRB 201608066). Written informed consent was obtained from all subjects participating in the trial. The trial was registered prior to patient enrollment at(ChiCTR-IOR-16010032, Principal investigator: Qulian Guo, Date of registration: 2016-11-26).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data published here are under the consent for publication. Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}